US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,491.54

+11.490.78%

Number of Gainers:9

Number of Losers:10

Number of Flat:1

PE:- -

High:1,493.79

Open:1,479.95

Low:1,472.49

Close:1,480.06

Loading ...

1 Healthcare Stock to Own for Decades and 2 to Ignore

Ema's Chmp: Adopted Extension to Existing Indication to Extend Use of Stelara to Children With Crohn’s Disease Weighing at Least 40 Kg

THOMSON REUTERS

1 Biotech Stock to Buy in 2025, and 1 to Avoid

Pfizer Updates DEI Webpage to Focus on Merit

MT Newswires Live

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older

With 79% ownership of the shares, Abbott Laboratories (NYSE:ABT) is heavily dominated by institutional owners

Simply Wall St.

UK health regulator approves Moderna's RSV vaccine for people aged 60 and over

BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over

New Treatments Give Hope to Patients With One of the Deadliest Cancers -- WSJ

Bernstein Remains a Hold on Pfizer (PFE)

3 Reasons ABBV is Risky and 1 Stock to Buy Instead

Wall Street's Greatest Dividend Stock Just Made History Again -- and 99.9% of Investors Have Never Heard of This Small-Cap Company

Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest

Bear of the Day: Krispy Kreme (DNUT)

APT Satellite Holdings to Announce Annual Results and Dividend Consideration

Barclays Remains a Buy on Vir Biotechnology (VIR)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1491.5414,"timestamp":1741619466149,"preClose":1480.0557,"halted":0,"volume":37430121,"delay":0,"changeRate":0.00776,"change":11.485718,"pbRate":4.037358,"amount":2163213078.554015,"amplitude":0.014387,"prevYearClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"turnoverRate":0.00242,"marketCap":1229212741393.5,"floatMarketCap":1207848127056.5,"peRate":31.999995},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1493.7869,"amplitude":0.014387,"preClose":1480.0557,"low":1472.4934,"pbRate":"4.037358","latestPrice":1491.5414,"volume":37430093,"delay":0,"open":1479.9548,"prevYearClose":1274.8187,"prevWeekClose":1480.0557,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1475.2046,"twentyDayClose":1354.9427,"sixtyDayClose":1302.6017,"secType":"PLATE","market":"US","turnoverRate":0.00242,"peRate":31.999995,"marketCap":1229212741393.5,"floatMarketCap":1207848127056.5,"timestamp":1741619465827,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":9,"down":10,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516630313","title":"1 Healthcare Stock to Own for Decades and 2 to Ignore","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630313","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516630313?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:02","pubTimestamp":1740747753,"startTime":"0","endTime":"0","summary":"Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 6.3%. This drop is a stark contrast from the S&P 500’s 5.1% gain.Only some companies are subject to these dynamics, however, and a handful of high-quality businesses can deliver earnings growth in any environment. Taking that into account, here is one healthcare stock poised to generate sustainable market-beating returns and two best left ignored.Founded in 2010 and widely known for its COVID-19 vaccine, Moderna  is a biotechnology company focused on developing messenger RNA  therapeutics and vaccines.Sales tumbled by 59% annually over the last two years, showing market trends are working against its favor during this cycle. Free cash flow margin dropped by 369.1 percentage points","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/1-healthcare-stock-own-decades-130233144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SGXZ23171101.USD","LU1720051017.SGD","LU2505996509.AUD","SG9999011175.SGD","BK4533","LU1670628061.USD","LU2357305700.SGD","LU0882574055.USD","SG9999004303.SGD","BK4532","HCSG","EVH","LU2430703251.USD","BK4137","ELV","LU0234570918.USD","LU1720051108.HKD","LU0006306889.USD","BK4534","LU1057294990.SGD","LU0061474960.USD","LU2362541273.HKD","LU0208291251.USD","LU2362541513.USD","SG9999003800.SGD","AMN","BK4568","BK4167","LU0114720955.EUR","LU0957791311.USD","LU0211331839.USD","LU0433182093.SGD","LU1489326972.SGD","LU0170899867.USD","LU0878866978.SGD","LU0314106906.USD","LU0251142724.SGD","LU2592432038.USD","BK4501","LU0345770308.USD","MRNA","SG9999001077.SGD","BK4139","LU1023059063.AUD","LU2244417387.USD","LU0106261372.USD","LU0985489474.SGD","LU2505996681.GBP","LU0289739699.SGD","LU1548497426.USD"],"gpt_icon":1},{"id":"2514326980","title":"Ema's Chmp: Adopted Extension to Existing Indication to Extend Use of Stelara to Children With Crohn’s Disease Weighing at Least 40 Kg","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326980","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326980?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:45","pubTimestamp":1740746748,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ0WM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IE00BSNM7G36.USD","LU0466842654.USD","BK4533","IE0034235303.USD","LU2129689605.HKD","LU0640476718.USD","LU1244550494.USD","LU1732800096.USD","IE000M9KFDE8.USD","LU1066053197.SGD","LU1023059063.AUD","LU1032955483.USD","IE00BFTCPJ56.SGD","LU2129689431.USD","LU1221951046.USD","LU1280957306.USD","BK4559","LU0203345920.USD","JNJ","LU1674673691.USD","BK4532","LU1778281490.HKD","LU2112291526.USD","BK4581","LU1057294990.SGD","LU1935042991.SGD","BK4592","BK4534","LU1244550221.USD","LU1894683264.USD","LU0345769631.USD","IE00B2B36J28.USD","IE00B42XCP33.USD","IE00B19Z3581.USD","LU0345770993.USD","BK4568","LU0795875169.SGD","LU1894683348.USD","LU2505996509.AUD","LU2430703095.HKD","IE00BJJMRZ35.SGD","IE00BVYPNV92.GBP","LU1914381329.SGD","LU2347655156.SGD","LU0234570918.USD","LU1066051498.USD","LU0889566641.SGD","BK4588","LU1196500208.SGD"],"gpt_icon":0},{"id":"2514032941","title":"1 Biotech Stock to Buy in 2025, and 1 to Avoid","url":"https://stock-news.laohu8.com/highlight/detail?id=2514032941","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514032941?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:00","pubTimestamp":1740744000,"startTime":"0","endTime":"0","summary":"Viking Therapeutics is developing promising therapies in a popular and rapidly growing therapeutic area.Novavax failed to gain traction in the COVID-19 market, and doesn't have hugely promising candidates.Viking Therapeutics  and Novavax  were two of the big winners in the biotech industry last year. Both companies saw their shares rise significantly; the former had exciting clinical progress, while the latter signed a lucrative deal with a biotech giant that had Wall Street cheering.Are these stocks worth buying in 2025 after their strong performance last year?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/28/1-biotech-stock-to-buy-in-2025-and-1-to-avoid/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4547","BK4139","BK4568","BK4585","BK4588","NVAX"],"gpt_icon":0},{"id":"2514328449","title":"Pfizer Updates DEI Webpage to Focus on Merit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514328449","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514328449?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:49","pubTimestamp":1740743395,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) revised its diversity, equity, and inclusion webpage Thursday to focus on merit, reflecting broader adjustments by companies in response to the Trump administration's rollback of DEI poli","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BBT3K403.USD","BK4007","BK4550","BK4585","SG9999013999.USD","IE00B19Z3581.USD","LU1894683348.USD","LU0225284248.USD","IE00BLSP4452.SGD","BK4533","LU0306806265.USD","LU0321505439.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","LU1883839398.USD","SG9999003800.SGD","SG9999011175.SGD","LU0122379950.USD","LU0456855351.SGD","LU1894683264.USD","LU0868494617.USD","PFE","SG9999002224.SGD","PFE.AU","LU0234572021.USD","LU0058720904.USD","BK4194","LU0985481810.HKD","BK4534","SGXZ57979304.SGD","BK4581","BK4592","LU0225771236.USD","DEI","LU0170899867.USD","LU1066053197.SGD","BK4588","BK4599","LU1066051498.USD","SG9999001176.USD","IE0002270589.USD","LU0321505868.SGD","BK4568","LU1023059063.AUD","LU0306807586.USD","IE00B19Z3B42.SGD","BK7095","BK4223","IE00BLSP4239.USD","LU0289739699.SGD"],"gpt_icon":1},{"id":"2514347556","title":"UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older","url":"https://stock-news.laohu8.com/highlight/detail?id=2514347556","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514347556?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:07","pubTimestamp":1740740878,"startTime":"0","endTime":"0","summary":"UPDATE 1-UK health regulator approves Moderna's RSV vaccine for adults aged 60 and olderAdds details on vaccine in paragraph 2, details on disease in paragraphs 3 & 4Feb 28  - Britain's health regulator said on Friday it has approved Moderna's MRNA.O vaccine for respiratory syncytial virus in adults 60 years and older. The shot, branded as mRESVIA, is for the prevention of lower respiratory tract disease in older adults, the Medicines and Healthcare products Regulatory Agency  said.RSV is a common virus that spreads very easily and causes infections that can be mild, with cold-like symptoms, but can also cause more serious problems, such as lung infections and pneumonia.Older adults are at risk of more serious complications that could lead to hospital admission and even death.GSK's GSK.L vaccine Arexvy and Pfizer's <PFE.N> shot Abrysvo are approved for use in individuals over the age of 60 in the UK.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PJ0V0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1302929846.USD","LU0203345920.USD","LU1202635105.USD","LU1228905540.USD","LU1064927863.SGD","LU1883839398.USD","LU1400636574.HKD","BK4568","LU1066051498.USD","GSK.UK","LU0971552830.HKD","BK5011","SG9999001176.SGD","BK4581","LU1035777561.USD","BK4548","LU1481599808.USD","LU1015430645.USD","BK4550","LU1481600234.SGD","BK4585","LU0225771236.USD","LU1057294990.SGD","LU1645745479.HKD","BK4534","BK4532","LU0289739699.SGD","LU0985481810.HKD","IE00BWDBJ516.SGD","MRNA","BK4592","IE00BBT3K403.USD","LU1228905037.USD","LU1400636491.USD","IE0034235071.USD","SG9999002232.USD","IE00BLSP4452.SGD","LU0203347892.USD","LU0234572021.USD","LU0545562505.USD","LU0306806265.USD","BK4588","BK4007","BK4139","SG9999001176.USD","LU1894683264.USD","BK4599","IE0002270589.USD","IE00BLSP4239.USD"],"gpt_icon":1},{"id":"2514893328","title":"With 79% ownership of the shares, Abbott Laboratories (NYSE:ABT) is heavily dominated by institutional owners","url":"https://stock-news.laohu8.com/highlight/detail?id=2514893328","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514893328?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:01","pubTimestamp":1740740463,"startTime":"0","endTime":"0","summary":"Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their trading actions. A total of 25 investors have a majority stake in the company with 49% ownership. Every investor in Abbott Laboratories  should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 79% ownership. That is, the group stands to benefit the most if the stock rises .Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait.In the chart below, we zoom in on the different ownership groups of Abbott Laboratories.Check out our latest analysis for Abbott Laboratories. The definition of an insider can differ slightly between different countries, but members of the board of dire","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/79-ownership-shares-abbott-laboratories-110103435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJJMRZ35.SGD","SGXZ23171101.USD","LU1691799644.USD","BK4533","ABT","BK4566","LU2112291526.USD","SG9999002232.USD","LU1989763690.USD","LU0234572021.USD","LU1023059063.AUD","NYSE","BK4585","LU1914381329.SGD","BK4568","LU2089984988.USD","LU2468319806.SGD","IE0002141913.USD","LU0122379950.USD","IE00B2B36J28.USD","BK4504","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4082","LU1721429741.USD","LU1057294990.SGD","LU1721429402.USD","SG9999004303.SGD","LU2237957902.USD","IE00B4R5TH58.HKD","LU0170899867.USD","LU1989763427.SGD","LU0868494617.USD","LU2237957811.SGD","BK4592","SG9999002224.SGD","LU0266013472.USD","LU2133065610.SGD","LU1061106388.HKD","BK4581","IE00BJT1NW94.SGD","BK4588"],"gpt_icon":1},{"id":"2514027344","title":"UK health regulator approves Moderna's RSV vaccine for people aged 60 and over","url":"https://stock-news.laohu8.com/highlight/detail?id=2514027344","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514027344?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:48","pubTimestamp":1740739699,"startTime":"0","endTime":"0","summary":"UK health regulator approves Moderna's RSV vaccine for people aged 60 and overFeb 28  - Britain's health regulator said on Friday it has approved Moderna's MRNA.O vaccine to protect patients aged 60 and over against lower respiratory tract disease caused by the respiratory syncytial virus .  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PJ0UR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","BK4585","BK4534","BK4533","BK4551","BK4532","BK4588","BK4501","BK4548","MRNA"],"gpt_icon":0},{"id":"2514901344","title":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over","url":"https://stock-news.laohu8.com/highlight/detail?id=2514901344","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514901344?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:37","pubTimestamp":1740739049,"startTime":"0","endTime":"0","summary":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And OverFeb 28  - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVERUK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSVSource text: [ID:]Further company coverage: MRNA.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4551","BK4533","BK4588","BK4548","BK4585","BK4501","BK4532","BK4534","MRNA","BK4568"],"gpt_icon":1},{"id":"2514344899","title":"New Treatments Give Hope to Patients With One of the Deadliest Cancers -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2514344899","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514344899?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:30","pubTimestamp":1740738600,"startTime":"0","endTime":"0","summary":"By Brianna Abbott | Photographs by Helynn Ospina for WSJ. Pranathi Perati was running out of time to treat her stage-four pancreatic cancer when she found out she would get another shot: a clinical trial testing a new experimental drug.Perati's odds were slim -- only 3% of late-stage pancreatic cancer patients are still alive after five years. And half of all pancreatic cancer patients live for less than a year after their diagnosis. For Perati, the drug, daraxonrasib from Revolution Medicines, has helped keep her alive for 17 months and counting.Pancreatic cancer is one of the toughest cancers to treat. Often caught late, it kills nearly 52,000 people in the U.S. each year, making it the country's third leading cause of cancer death, behind lung and colorectal. Case rates have gradually increased, particularly among younger women, in part because of rising obesity rates.Researchers believe that could change with newer therapies, particularly those that target KRAS. The gene acts as a ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0456855351.SGD","BK4007","BK4533","LU0985481810.HKD","LU1894683348.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","LU0225771236.USD","PFE","IE0002270589.USD","LU0170899867.USD","LU0321505439.SGD","LU1883839398.USD","BK4599","SG9999003800.SGD","LU0289739699.SGD","LU1066051498.USD","LU0058720904.USD","LU1023059063.AUD","BK4581","SG9999001176.SGD","LU1066053197.SGD","IE00B19Z3581.USD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0234572021.USD","BK4534","SG9999001176.USD","LU0306806265.USD","SG9999002232.USD","BK4211","LU0225284248.USD","LU0306807586.USD","LU0868494617.USD","LU0122379950.USD","SG9999013999.USD","HOPE","SG9999002224.SGD","LU0321505868.SGD","BK4568","BK4585","BK4588","LU1894683264.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD","BK4592"],"gpt_icon":0},{"id":"2514411973","title":"Bernstein Remains a Hold on Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514411973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514411973?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:16","pubTimestamp":1740737777,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. The company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pfizer-pfe-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pfizer-pfe-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234572021.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0170899867.USD","LU0321505868.SGD","BK4534","LU1883839398.USD","BK4533","LU0225284248.USD","LU1894683348.USD","LU1057294990.SGD","BK4588","LU0306806265.USD","IE00BBT3K403.USD","LU1023059063.AUD","SG9999013999.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU0321505439.SGD","LU1894683264.USD","SGXZ57979304.SGD","BK4585","LU0456855351.SGD","SG9999001176.SGD","IE00BLSP4239.USD","SG9999002232.USD","SG9999011175.SGD","BK4592","LU0225771236.USD","BK4568","IE00B19Z3581.USD","LU0289739699.SGD","BK4599","LU0868494617.USD","LU0985481810.HKD","BK4007","BK4581","PFE","LU0306807586.USD","SG9999001176.USD","LU1066051498.USD","LU0058720904.USD","SG9999002224.SGD","LU1066053197.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4550"],"gpt_icon":0},{"id":"2514326532","title":"3 Reasons ABBV is Risky and 1 Stock to Buy Instead","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326532","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326532?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:07","pubTimestamp":1740733642,"startTime":"0","endTime":"0","summary":"AbbVie trades at $205.51 per share and has stayed right on track with the overall market, gaining 5.2% over the last six months. At the same time, the S&P 500 has returned 5.1%.Is now the time to buy AbbVie, or should you be careful about including it in your portfolio?Get the full stock story straight from our expert analysts, it’s free.We don't have much confidence in AbbVie. Here are three reasons why we avoid ABBV and a stock we'd rather own.Founded in 2013 as a spin-off from Abbott Laboratories , AbbVie  is a biopharmaceutical company that develops and sells prescription medicines focused on areas like immunology , oncology , and neuroscience .AbbVie isn’t a terrible business, but it isn’t one of our picks. That said, the stock currently trades at 16.7× forward price-to-earnings . Beauty is in the eye of the beholder, but we don’t really see a big opportunity at the moment. We're fairly confident there are better stocks to buy right now. Let us point you toward a dominant Aerospac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-reasons-abbv-risky-1-090722642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0256863902.USD","IE00BSNM7G36.USD","BK4568","ABT","LU0943347566.SGD","LU1093756325.SGD","BK4139","BK4585","SG9999003800.SGD","LU1061106388.HKD","IE00BDGV0183.EUR","LU0266013472.USD","LU1551013425.SGD","LU2347655156.SGD","IE00BVYPNV92.GBP","BK4592","LU1914381329.SGD","BK4566","LU0310800379.SGD","LU0965508806.USD","LU0310799852.SGD","LU0882574055.USD","LU0158827948.USD","LU2468319806.SGD","LU1585245621.USD","SG9999015986.USD","LU1037948541.HKD","LU0689472784.USD","BK4581","LU1093756168.USD","IE00B42XCP33.USD","BK4559","LU0203345920.USD","LU0708994859.HKD","LU0795875086.SGD","LU1291159041.SGD","BK4082","IE00B4R5TH58.HKD","LU0949170772.SGD","IE00BVYPNW00.USD","ABBV","LU2089984988.USD","LU2237443465.HKD","LU1267930573.SGD","LU1721429741.USD","LU1267930490.SGD","SG9999001440.SGD","SG9999002232.USD","LU0211328371.USD"],"gpt_icon":0},{"id":"2514492183","title":"Wall Street's Greatest Dividend Stock Just Made History Again -- and 99.9% of Investors Have Never Heard of This Small-Cap Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2514492183","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514492183?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:06","pubTimestamp":1740733560,"startTime":"0","endTime":"0","summary":"This virtually unknown company has been paying a continuous dividend for six decades longer than any other U.S. stock.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/28/wall-street-greatest-dividend-stock-made-history/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0203345920.USD","LU1196500208.SGD","SG9999001440.SGD","LU0122379950.USD","BK4568","BK4127","IE00B1BXHZ80.USD","JNJ","LU1066051498.USD","LU1868836914.USD","LU2505996509.AUD","SG9999004303.SGD","IE00BFTCPJ56.SGD","LU1988902786.USD","ISBC","IE00B4R5TH58.HKD","LU0175139822.USD","IE00BJT1NW94.SGD","LU1720051017.SGD","LU2112291526.USD","LU0098860793.USD","LU1244550221.USD","BK4534","LU0096364046.USD","LU2237443549.SGD","LU2129689514.USD","IE00B19Z3B42.SGD","LU0971096721.USD","LU2264538146.SGD","LU2237443382.USD","IE000M9KFDE8.USD","LU1363072403.SGD","LU1868837136.USD","BK4592","IE00BBT3K403.USD","LU2271345857.HKD","LU1868836757.USD","LU0289960550.SGD","LU2592432038.USD","LU0006306889.USD","LU1670710661.SGD","LU1023059063.AUD","LU1732799900.SGD","LU1670711123.USD","AAA","LU1116320901.HKD","LU2089283258.USD","BK4533","LU0106261372.USD"],"gpt_icon":1},{"id":"2514323675","title":"Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest","url":"https://stock-news.laohu8.com/highlight/detail?id=2514323675","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514323675?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:04","pubTimestamp":1740733452,"startTime":"0","endTime":"0","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting  results from Q4. Today, we are looking at medical devices & supplies - diversified stocks, starting with Stryker .The 5 medical devices & supplies - diversified stocks we track reported a strong Q4. As a group, revenues beat analysts’ consensus estimates by 1.8% while next quarter’s revenue guidance was in line.In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results.Stryker reported revenues of $6.44 billion, up 10.7% year on year. This print exceeded analysts’ expectations by 1.4%. Overall, it was a strong quarter for the company with an impressive beat of analysts’ organic revenue estimates and a decent beat of analysts’ EPS estimates.“We delivered another year of double-digit organic sales growth while continuing to expand adjusted operating margins and drive adjusted earnings per share growth,” ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-devices-supplies-diversified-stocks-090412604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2491049909.HKD","LU0528227936.USD","LU0345769631.USD","LU0048584097.USD","LU2237957902.USD","BSX","LU0234572021.USD","BK4585","LU1153585028.USD","BK4082","LU2491050071.SGD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU0187121727.USD","LU0690374961.EUR","BK4568","LU1989772923.USD","LU2265009873.SGD","LU2133065610.SGD","LU0251132253.USD","LU2237957811.SGD","LU1989772840.SGD","GB00B4QBRK32.GBP","LU0310799852.SGD","NYSE","ABT","LU0238689110.USD","LU1023059063.AUD","LU2506951958.HKD","BK4566","GB00B4LPDJ14.GBP","LU0823417737.USD","NEOG","SYK","LU2089984988.USD","BAX","LU0114720955.EUR","BK4592","IE00BJT1NW94.SGD","LU1989764748.USD","LU2098885051.SGD","LU0162691827.USD","BK4504","LU2324357040.USD","LU0122379950.USD","LU2087625088.SGD","LU0353189680.USD","LU0690374615.EUR","LU1691799644.USD","LU2506952170.USD"],"gpt_icon":0},{"id":"2514694341","title":"Bear of the Day: Krispy Kreme (DNUT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514694341","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514694341?lang=en_us&edition=fundamental","pubTime":"2025-02-28 17:00","pubTimestamp":1740733200,"startTime":"0","endTime":"0","summary":"Zacks Rank #5  stock Krispy Kreme  is a Charlotte-based. Globally recognized sweet treat brand, best known for its signature “Original Glazed” doughnut. Krispy Kreme’s company model consists of a fresh doughnut shop network , retail strategic partnerships, and e-commerce and delivery growth. The company operates mainly in the US and Canada; however, its international footprint extends to the UK, Australia, and Mexico. In addition, the company has a diversified sweet treat portfolio that includes entities like Insomnia Cookies. That said, Krispy Kreme’s success mainly depends on its fresh doughnuts segment.Though New Year’s health resolutions are nothing new, a 2025 Ipsos poll found that “Younger Americans are particularly likely to resolve to healthier living – and even if you’ve been keeping up with Gen Z wellness trends, the extent of that enthusiasm is striking.Krispy Kreme, a globally recognized sweet treat brand heavily reliant on its fresh doughnut segment, faces significant chal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bear-day-krispy-kreme-dnut-090000398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTX","BK4139","BK4568","BK4585","BK4009","HHS","BK4551","BK4209","BK4588","BK4548","DNUT","BK4535","BK4539"],"gpt_icon":0},{"id":"2514489123","title":"APT Satellite Holdings to Announce Annual Results and Dividend Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2514489123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514489123?lang=en_us&edition=fundamental","pubTime":"2025-02-28 16:44","pubTimestamp":1740732282,"startTime":"0","endTime":"0","summary":"APT Satellite Holdings ( ($HK:1045) ) has provided an update. APT Satellite Holdings Limited has announced that its board of directors will meet on...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apt-satellite-holdings-to-announce-annual-results-and-dividend-consideration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apt-satellite-holdings-to-announce-annual-results-and-dividend-consideration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APT","BK4568","BK4086"],"gpt_icon":0},{"id":"2514531412","title":"Barclays Remains a Buy on Vir Biotechnology (VIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514531412","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514531412?lang=en_us&edition=fundamental","pubTime":"2025-02-28 16:16","pubTimestamp":1740730596,"startTime":"0","endTime":"0","summary":"In a report released today, Gena Wang from Barclays maintained a Buy rating on Vir Biotechnology (VIR – Research Report), with a price target of $3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-vir-biotechnology-vir?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-vir-biotechnology-vir?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4535","VIR","BK4585","BK4568"],"gpt_icon":0}],"pageSize":16,"totalPage":19,"pageCount":13,"totalSize":299}]}}